Fexofenadine, Pseudoephedrine

Allegra-D

60 MG + 120 MG Tablet (Immediate- And Extended-Release)CanadaMarketedAuthorised 29 Apr 1999

In other countries

The same active substances on other registers, the same brand first.

Allegra DBrazil · Opella Healthcare Brazil LtdaSame brand
Allegra DBrazil · Sanofi Medley Farmacêutica Ltda.Same brand
Allegra DBrazil · Sanofi-Aventis Farmacêutica LtdaSame brand
Allegra-D 12 Hour Allergy and CongestionUnited States · 60MG; 120MG · tablet, extended release · Chattem SanofiSame brand
Allegra-D 24 Hour Allergy and CongestionUnited States · 180MG; 240MG · tablet, extended release · Chattem SanofiSame brand
Telfast D TabletSingapore · 60 mg + 120 mg · tablet, film coated · Opella Healthcare Singapore Pte. LTD.Same form
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fexofenadine, Pseudoephedrine

Allegra-D

60 MG + 120 MG Tablet (Immediate- And Extended-Release)CanadaMarketedAuthorised 29 Apr 1999

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

United States · 180MG; 240MG, 60MG; 120MG · tablet, extended release · Impax Pharms

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Fexofenadine, Pseudoephedrine
Strength: 60 MG + 120 MG
Dosage form: Tablet (Immediate- And Extended-Release)
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 29 Apr 1999
Registration: DIN 02239853
Marketing authorisation holder: Sanofi Consumer Health INC
ATC code: R01BA52
Group: Respiratory system
Supply: NON-PRESCRIPTION DRUGS